Barbara K Finck

Title: Barbara K Finck: Innovator in Medical Treatments

Introduction

Barbara K Finck is a prominent inventor based in Mercer Island, Washington. She has made significant contributions to the field of medical treatments, particularly in the areas of neurodegenerative diseases and inflammatory disorders. With a total of five patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is focused on a PPARγ agonist for the treatment of progressive supranuclear palsy. This invention outlines methods for treating progressive supranuclear palsy or its symptoms using PPARγ agonists, specifically the compound known as INT 131. The patent details methods for selecting subjects with elevated levels of neurofilament light chain protein and administering a pharmaceutical composition containing a therapeutically effective amount of INT 131. Another significant patent involves the soluble tumor necrosis factor receptor for treating medical disorders characterized by elevated levels or abnormal expression of TNFα. This invention includes methods and compositions for administering a TNFα antagonist, such as recombinant TNFR:Fc.

Career Highlights

Throughout her career, Barbara has worked with notable companies in the biotechnology sector, including Immunex Corporation and Coherus Biosciences, Inc. Her experience in these organizations has allowed her to develop innovative solutions to complex medical challenges.

Collaborations

Barbara has collaborated with esteemed colleagues such as David E Weinstein and Sarita K Jain. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Barbara K Finck is a trailblazer in the field of medical innovation, with a focus on developing treatments for serious health conditions. Her patents and collaborations reflect her commitment to improving patient outcomes through scientific advancement.